Advanced phenotyping in hypersensitivity drug reactions to NSAIDs

Clinical and Experimental Allergy

Volumn 43, Issue 10, 2013, Pages 1097-1109

  Ayuso, P ^a   Blanca Lopez N ^b   Dona I ^a   Torres, M J ^a   Gueant Rodriguez R M ^c   Canto, G ^b   Sanak, M ^d   Mayorga, C ^a   Gueant J L ^c   Blanca, M ^a,c   Cornejo Garcia J A ^a  

^a HOSPITAL REGIONAL UNIVERSITARIO DE MÁLAGA   (Spain)

^b HOSPITAL UNIVERSITARIO INFANTA LEONOR   (Spain)

^c INSERM   (France)

^d JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

ACETIC ACID DERIVATIVE; ACETYLSALICYLIC ACID; CYCLOOXYGENASE 1; DICLOFENAC; DIPYRONE; ETORICOXIB; IBUPROFEN; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G; INDOMETACIN; INTERLEUKIN 13; INTERLEUKIN 4; INTERLEUKIN 5; MEFENAMIC ACID; NONSTEROID ANTIINFLAMMATORY AGENT; PARACETAMOL; PROPIONIC ACID; PYRAZOLONE DERIVATIVE;

ANAPHYLAXIS; ANGIONEUROTIC EDEMA; ARACHIDONIC ACID METABOLISM; ASEPTIC MENINGITIS; ASPIRIN EXACERBATED CUTANEOUS DISEASE; ASPIRIN EXACERBATED RESPIRATORY DISEASE; ASTHMA; ATOPY; BULLOUS SKIN DISEASE; CELLULAR IMMUNITY; CHRONIC URTICARIA; CYTOTOXIC T LYMPHOCYTE; DISEASE ASSOCIATION; DRUG HYPERSENSITIVITY; DRUG RESPONSE; ENZYME INHIBITION; FIXED DRUG ERUPTION; FOOD ALLERGY; HUMAN; MACULOPAPULAR RASH; MULTIPLE NSAID INDUCED URTICARIA ANGIOEDEMA; NATURAL KILLER CELL; NEPHRITIS; NOSE OBSTRUCTION; NOSE POLYP; PATHOPHYSIOLOGY; PHENOTYPE; PHOTODERMATOSIS; PNEUMONIA; PRIORITY JOURNAL; REVIEW; RHINITIS; RHINORRHEA; RHINOSINUSITIS; SKIN DISEASE; URTICARIA;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; DRUG HYPERSENSITIVITY; HUMANS; PHENOTYPE;

EID: 84880111152     PISSN: 09547894     EISSN: 13652222     Source Type: Journal    
DOI: 10.1111/cea.12140     Document Type: Review

References (151)

1. Rubio M, Bousquet PJ, Gomes E, Romano A, Demoly P. Results of drug hypersensitivity evaluations in a large group of children and adults. Clin Exp Allergy 2012; 42:123-30.
2. Kowalski ML, Makowska JS, Blanca M et al. Hypersensitivity to nonsteroidal anti-inflammatory drugs (NSAIDs) - classification, diagnosis and management: review of the EAACI/ENDA(#) and GA2LEN/HANNA*. Allergy 2011; 66:818-29.
3. Asero R, Bavbek S, Blanca M et al. Clinical management of patients with a history of urticaria/angioedema induced by multiple NSAIDs: an expert panel review. Int Arch Allergy Immunol 2012; 160:126-33.
4. Thong BY, Tan TC. Epidemiology and risk factors for drug allergy. Br J Clin Pharmacol 2011; 71:684-700.
5. Sanz ML, Gamboa PM, Mayorga C. Basophil activation tests in the evaluation of immediate drug hypersensitivity. Curr Opin Allergy Clin Immunol 2009; 9:298-304.
6. Mockenhaupt M. Epidemiology of cutaneous adverse drug reactions. Chem Immunol Allergy 2012; 97:1-17.
7. Gamboa PM. The epidemiology of drug allergy-related consultations in Spanish Allergology services: Alergologica-2005. J Investig Allergol Clin Immunol 2009; 19(Suppl 2):45-50.
8. Messaad D, Sahla H, Benahmed S, Godard P, Bousquet J, Demoly P. Drug provocation tests in patients with a history suggesting an immediate drug hypersensitivity reaction. Ann Intern Med 2004; 140:1001-6.
9. Chalabianloo F, Berstad A, Schjott J, Riedel B, Irgens A, Florvaag E. Clinical characteristics of patients with drug hypersensitivity in Norway: a single-centre study. Pharmacoepidemiol Drug Saf 2011; 20:506-13.
10. Doña I, Blanca-Lopez N, Torres MJ et al. Drug hypersensitivity reactions: response patterns, drug involved, and temporal variations in a large series of patients. J Investig Allergol Clin Immunol 2012; 22:363-71.
11. Gomes ER, Demoly P. Epidemiology of hypersensitivity drug reactions. Curr Opin Allergy Clin Immunol 2005; 5:309-16.
12. Johansson SG, Bieber T, Dahl R et al. Revised nomenclature for allergy for global use: report of the Nomenclature Review Committee of the World Allergy Organization, October 2003. J Allergy Clin Immunol 2004; 113:832-6.
13. Torres MJ, Gomez F, Doña I et al. Diagnostic evaluation of patients with nonimmediate cutaneous hypersensitivity reactions to iodinated contrast media. Allergy 2012; 67:929-35.
14. Nettis E, Marcandrea M, Maggio GD, Ferrannini A, Tursi A. Retrospective analysis of drug-induced urticaria and angioedema: a survey of 2287 patients. Immunopharmacol Immunotoxicol 2001; 23:585-95.
15. Doña I, Blanca-Lopez N, Cornejo-Garcia JA et al. Characteristics of subjects experiencing hypersensitivity to non-steroidal anti-inflammatory drugs: patterns of response. Clin Exp Allergy 2011; 41:86-95.
16. Caimmi S, Caimmi D, Bousquet PJ, Demoly P. How can we better classify NSAID hypersensitivity reactions?-validation from a large database. Int Arch Allergy Immunol 2012; 159:306-12.
17. Roberts LJ, Morrow JD. Analgesic-antipyretic and inflammatory agents and drugs employed in the treatment of gout. In: Hardman JG, Limbird LL, Goodman Gilman A, eds. The pharmacological basis of therapeutics. 10th Edn. New York: McGraw Hill, 2001:687-731
18. Szczeklik A, Gryglewski RJ, Czerniawska-Mysik G. Relationship of inhibition of prostaglandin biosynthesis by analgesics to asthma attacks in aspirin-sensitive patients. Br Med J 1975; 1:67-9.
19. Setkowicz M, Mastalerz L, Podolec-Rubis M, Sanak M, Szczeklik A. Clinical course and urinary eicosanoids in patients with aspirin-induced urticaria followed up for 4 years. J Allergy Clin Immunol 2009; 123:174-8.
20. Asero R. Risk factors for acetaminophen and nimesulide intolerance in patients with NSAID-induced skin disorders. Ann Allergy Asthma Immunol 1999; 82:554-8.
21. Kim SH, Nam EJ, Kim YK, Ye YM, Park HS. Functional variability of the adenosine A3 receptor (ADORA3) gene polymorphism in aspirin-induced urticaria. Br J Dermatol 2010; 163:977-85.
22. Kim SH, Son JK, Yang EM, Kim JE, Park HS. A functional promoter polymorphism of the human IL18 gene is associated with aspirin-induced urticaria. Br J Dermatol 2011; 165:976-84.
23. Samter M, Beers RF Jr. Intolerance to aspirin. Clinical studies and consideration of its pathogenesis. Ann Intern Med 1968; 68:975-83.
24. Lee RU, Stevenson DD. Aspirin-exacerbated respiratory disease: evaluation and management. Allergy Asthma Immunol Res 2011; 3:3-10.
25. Jenkins C, Costello J, Hodge L. Systematic review of prevalence of aspirin induced asthma and its implications for clinical practice. BMJ 2004; 328:434.
26. Szczeklik A, Nizankowska E, Duplaga M. Natural history of aspirin-induced asthma. AIANE Investigators. European Network on Aspirin-Induced Asthma. Eur Respir J 2000; 16:432-6.
27. Sanchez-Borges M. NSAID hypersensitivity (respiratory, cutaneous, and generalized anaphylactic symptoms). Med Clin North Am 2010; 94:853-64, xiii.
28. Baldassarre S, Schandene L, Choufani G, Michils A. Asthma attacks induced by low doses of celecoxib, aspirin, and acetaminophen. J Allergy Clin Immunol 2006; 117:215-7.
29. Kaplan AP. Clinical practice. Chronic urticaria and angioedema. N Engl J Med 2002; 346:175-9.
30. Stevenson DD, Simon RA, Zuraw BL. Sensitivity to aspirin and nonsteroidal antiinflammatory drugs. In: Adkinson NF Jr, Yunginger JW, Busse WW, Bochner BS, Holgate ST, Simons FER, eds. Middleton's Allergy: Principles and Practice. 6th Edn. Philadelphia: Mosby, 2003, 1695-710.
31. Quiralte J. Aspirin-induced isolated periorbital angioedema. Ann Allergy Asthma Immunol 1998; 81:459.
32. Capriles-Behrens E, Caplin J, Sanchez-Borges M. NSAID facial angioedema in a selected pediatric atopic population. J Investig Allergol Clin Immunol 2000; 10:277-9.
33. Kidon MI, Kang LW, Chin CW et al. Early presentation with angioedema and urticaria in cross-reactive hypersensitivity to nonsteroidal antiinflammatory drugs among young, Asian, atopic children. Pediatrics 2005; 116:e675-80.
34. Sanchez-Borges M, Capriles-Hulett A. Atopy is a risk factor for non-steroidal anti-inflammatory drug sensitivity. Ann Allergy Asthma Immunol 2000; 84:101-6.
35. Sánchez-Borges M, Acevedo N, Caraballo L, Capriles-Hulett A, Caballero-Fonseca F. Increased total and mite-specific immunoglobulin E in patients with aspirin-induced urticaria and angioedema. J Investig Allergol Clin Immunol 2010; 20:139-45.
36. Quiralte J, Blanco C, Castillo R, Delgado J, Carrillo T. Intolerance to nonsteroidal antiinflammatory drugs: results of controlled drug challenges in 98 patients. J Allergy Clin Immunol 1996; 98:678-85.
37. Stevenson DD, Sanchez-Borges M, Szczeklik A. Classification of allergic and pseudoallergic reactions to drugs that inhibit cyclooxygenase enzymes. Ann Allergy Asthma Immunol 2001; 87:177-80.
38. Quiralte J, Blanco C, Delgado J et al. Challenge-based clinical patterns of 223 Spanish patients with nonsteroidal anti-inflammatory-drug-induced-reactions. J Investig Allergol Clin Immunol 2007; 17:182-8.
39. Leeyaphan C, Kulthanan K, Jongjarearnprasert K, Dhana N. Drug-induced angioedema without urticaria: prevalence and clinical features. J Eur Acad Dermatol Venereol 2010; 24:685-91.
40. Himly M, Jahn-Schmid B, Pittertschatscher K et al. IgE-mediated immediate-type hypersensitivity to the pyrazolone drug propyphenazone. J Allergy Clin Immunol 2003; 111:882-8.
41. Schneider CH, Kasper MF, de Weck AL, Rolli H, Angst BD. Diagnosis of antibody-mediated drug allergy. Pyrazolinone and pyrazolidinedione cross-reactivity relationships. Allergy 1987; 42:597-603.
42. Blanca M, Perez E, Garcia JJ et al. Angioedema and IgE antibodies to aspirin: a case report. Ann Allergy 1989; 62:295-8.
43. Torres MJ, Blanca M. The complex clinical picture of beta-lactam hypersensitivity: penicillins, cephalosporins, monobactams, carbapenems, and clavams. Med Clin North Am 2010; 94:805-20, xii.
44. Harrer A, Lang R, Grims R et al. Diclofenac hypersensitivity: antibody responses to the parent drug and relevant metabolites. PLoS ONE 2010; 5:e13707.
45. Gomez E, Blanca-Lopez N, Torres MJ et al. Immunoglobulin E-mediated immediate allergic reactions to dipyrone: value of basophil activation test in the identification of patients. Clin Exp Allergy 2009; 39:1217-24.
46. Posadas SJ, Pichler WJ. Delayed drug hypersensitivity reactions - new concepts. Clin Exp Allergy 2007; 37:989-99.
47. Roujeau JC, Kelly JP, Naldi L et al. Medication use and the risk of Stevens-Johnson syndrome or toxic epidermal necrolysis. N Engl J Med 1995; 333:1600-7.
48. Levi N, Bastuji-Garin S, Mockenhaupt M et al. Medications as risk factors of Stevens-Johnson syndrome and toxic epidermal necrolysis in children: a pooled analysis. Pediatrics 2009; 123:e297-304.
49. Mockenhaupt M, Kelly JP, Kaufman D, Stern RS. The risk of Stevens-Johnson syndrome and toxic epidermal necrolysis associated with nonsteroidal antiinflammatory drugs: a multinational perspective. J Rheumatol 2003; 30:2234-40.
50. Pichler WJ. Delayed drug hypersensitivity reactions. Ann Intern Med 2003; 139:683-93.
51. Sanchez-Borges M, Capriles-Hulett A, Caballero-Fonseca F. Risk of skin reactions when using ibuprofen-based medicines. Expert Opin Drug Saf 2005; 4:837-48.
52. Cornejo-Garcia JA, Blanca-Lopez N, Doña I et al. Hypersensitivity reactions to non-steroidal anti-inflammatory drugs. Curr Drug Metab 2009; 10:971-80.
53. Castrejon JL, Berry N, El-Ghaiesh S et al. Stimulation of human T cells with sulfonamides and sulfonamide metabolites. J Allergy Clin Immunol 2010; 125:411-8, e4.
54. Morrow JD, Oates JA, Roberts LJ 2nd et al. Increased formation of thromboxane in vivo in humans with mastocytosis. J Invest Dermatol 1999; 113:93-7.
55. Nizankowska-Mogilnicka E, Bochenek G, Mastalerz L et al. EAACI/GA2LEN guideline: aspirin provocation tests for diagnosis of aspirin hypersensitivity. Allergy 2007; 62:1111-8.
56. Macy E, Bernstein JA, Castells MC et al. Aspirin challenge and desensitization for aspirin-exacerbated respiratory disease: a practice paper. Ann Allergy Asthma Immunol 2007; 98:172-4.
57. Milewski M, Mastalerz L, Nizankowska E, Szczeklik A. Nasal provocation test with lysine-aspirin for diagnosis of aspirin-sensitive asthma. J Allergy Clin Immunol 1998; 101:581-6.
58. Alonso-Llamazares A, Martinez-Cocera C, Dominguez-Ortega J, Robledo-Echarren T, Cimarra-Alvarez M, Mesa del Castillo M. Nasal provocation test (NPT) with aspirin: a sensitive and safe method to diagnose aspirin-induced asthma (AIA). Allergy 2002; 57:632-5.
59. Berges-Gimeno MP, Simon RA, Stevenson DD. The natural history and clinical characteristics of aspirin-exacerbated respiratory disease. Ann Allergy Asthma Immunol 2002; 89:474-8.
60. Szczeklik A, Undas A, Sanak M, Frolow M, Wegrzyn W. Relationship between bleeding time, aspirin and the PlA1/A2 polymorphism of platelet glycoprotein IIIa. Br J Haematol 2000; 110:965-7.
61. Bochenek G, Nizankowska-Mogilnicka E. Aspirin-exacerbated respiratory disease: clinical disease and diagnosis. Immunol Allergy Clin N Am 2013; 33:147-61.
62. Graefe H, Roebke C, Schafer D, Meyer JE. Aspirin sensitivity and chronic rhinosinusitis with polyps: a fatal combination. J Allergy (Cairo) 2012; doi: 10.1155/2012/817910. [Epub ahead of print].
63. Koga T, Oshita Y, Kamimura T, Koga H, Aizawa H. Characterisation of patients with frequent exacerbation of asthma. Respir Med 2006; 100:273-8.
64. Aberer W, Bircher A, Romano A et al. Drug provocation testing in the diagnosis of drug hypersensitivity reactions: general considerations. Allergy 2003; 58:854-63.
65. Viola M, Rumi G, Valluzzi RL, Gaeta F, Caruso C, Romano A. Assessing potential determinants of positive provocation tests in subjects with NSAID hypersensitivity. Clin Exp Allergy 2011; 41:96-103.
66. Blanca-Lopez N, Torres MJ, Doña I et al. Value of the clinical history in the diagnosis of urticaria/angioedema induced by NSAIDs with cross-intolerance. Clin Exp Allergy 2013; 43:85-91.
67. Gomez E, Torres MJ, Mayorga C, Blanca M. Immunologic evaluation of drug allergy. Allergy Asthma Immunol Res 2012; 4:251-63.
68. Canto MG, Andreu I, Fernandez J, Blanca M. Selective immediate hypersensitivity reactions to NSAIDs. Curr Opin Allergy Clin Immunol 2009; 9:293-7.
69. Macias E, Ruiz A, Moreno E, Laffond E, Davila I, Lorente F. Usefulness of intradermal test and patch test in the diagnosis of nonimmediate reactions to metamizol. Allergy 2007; 62:1462-4.
70. Romano A, Torres MJ, Castells M, Sanz ML, Blanca M. Diagnosis and management of drug hypersensitivity reactions. J Allergy Clin Immunol 2011; 127:S67-73.
71. Hackstein H, Morelli AE, Larregina AT et al. Aspirin inhibits in vitro maturation and in vivo immunostimulatory function of murine myeloid dendritic cells. J Immunol 2001; 166:7053-62.
72. Gaber F, Daham K, Higashi A et al. Increased levels of cysteinyl-leukotrienes in saliva, induced sputum, urine and blood from patients with aspirin-intolerant asthma. Thorax 2008; 63:1076-82.
73. Szczeklik A, Sladek K, Dworski R et al. Bronchial aspirin challenge causes specific eicosanoid response in aspirin-sensitive asthmatics. Am J Respir Crit Care Med 1996; 154:1608-14.
74. Cowburn AS, Sladek K, Soja J et al. Overexpression of leukotriene C4 synthase in bronchial biopsies from patients with aspirin-intolerant asthma. J Clin Invest 1998; 101:834-46.
75. Antczak A, Montuschi P, Kharitonov S, Gorski P, Barnes PJ. Increased exhaled cysteinyl-leukotrienes and 8-isoprostane in aspirin-induced asthma. Am J Respir Crit Care Med 2002; 166:301-6.
76. Swierczynska M, Nizankowska-Mogilnicka E, Zarychta J, Gielicz A, Szczeklik A. Nasal versus bronchial and nasal response to oral aspirin challenge: clinical and biochemical differences between patients with aspirin-induced asthma/rhinitis. J Allergy Clin Immunol 2003; 112:995-1001.
77. Sanak M, Kielbasa B, Bochenek G, Szczeklik A. Exhaled eicosanoids following oral aspirin challenge in asthmatic patients. Clin Exp Allergy 2004; 34:1899-904.
78. Sanak M, Gielicz A, Bochenek G, Kaszuba M, Nizankowska-Mogilnicka E, Szczeklik A. Targeted eicosanoid lipidomics of exhaled breath condensate provide a distinct pattern in the aspirin-intolerant asthma phenotype. J Allergy Clin Immunol 2011; 127:1141-7, e2.
79. Higashi N, Taniguchi M, Mita H, Osame M, Akiyama K. A comparative study of eicosanoid concentrations in sputum and urine in patients with aspirin-intolerant asthma. Clin Exp Allergy 2002; 32:1484-90.
80. Higashi N, Taniguchi M, Mita H, Yamaguchi H, Ono E, Akiyama K. Aspirin-intolerant asthma (AIA) assessment using the urinary biomarkers, leukotriene E4 (LTE4) and prostaglandin D2 (PGD2) metabolites. Allergol Int 2012; 61:393-403.
81. Ono E, Taniguchi M, Higashi N et al. Increase in salivary cysteinyl-leukotriene concentration in patients with aspirin-intolerant asthma. Allergol Int 2011; 60:37-43.
82. Yamaguchi H, Higashi N, Mita H et al. Urinary concentrations of 15-epimer of lipoxin A(4) are lower in patients with aspirin-intolerant compared with aspirin-tolerant asthma. Clin Exp Allergy 2011; 41:1711-8.
83. Laidlaw TM, Kidder MS, Bhattacharyya N et al. Cysteinyl leukotriene overproduction in aspirin-exacerbated respiratory disease is driven by platelet-adherent leukocytes. Blood 2012; 119:3790-8.
84. Grattan CE. Aspirin sensitivity and urticaria. Clin Exp Dermatol 2003; 28:123-7.
85. Sanchez-Borges M, Capriles-Hulett A, Caballero-Fonseca F. Cutaneous reactions to aspirin and nonsteroidal antiinflammatory drugs. Clin Rev Allergy Immunol 2003; 24:125-36.
86. Zembowicz A, Mastalerz L, Setkowicz M, Radziszewski W, Szczeklik A. Safety of cyclooxygenase 2 inhibitors and increased leukotriene synthesis in chronic idiopathic urticaria with sensitivity to nonsteroidal anti-inflammatory drugs. Arch Dermatol 2003; 139:1577-82.
87. Naldi L, Conforti A, Venegoni M et al. Cutaneous reactions to drugs. An analysis of spontaneous reports in four Italian regions. Br J Clin Pharmacol 1999; 48:839-46.
88. Kulthanan K, Jiamton S, Boochangkool K, Jongjarearnprasert K. Angioedema: clinical and etiological aspects. Clin Dev Immunol 2007; 2007:26438.
89. Nussberger J, Cugno M, Cicardi M. Bradykinin-mediated angioedema. N Engl J Med 2002; 347:621-2.
90. Botey J, Navarro C, Aulesa C, Marin A, Eseverri JL. Acetyl salicylic acid induced-urticaria and/or angioedema in atopic children. Allergol Immunopathol (Madr) 1988; 16:43-7.
91. Diaz Jara M, Perez Montero A, Gracia Bara MT, Cabrerizo S, Zapatero L, Martinez Molero MI. Allergic reactions due to ibuprofen in children. Pediatr Dermatol 2001; 18:66-7.
92. Hassani A, Ponvert C, Karila C, Le Bourgeois M, De Blic J, Scheinmann P. Hypersensitivity to cyclooxygenase inhibitory drugs in children: a study of 164 cases. Eur J Dermatol 2008; 18:561-5.
93. Sanchez-Borges M, Fernandez-Caldas E, Capriles-Hulett A, Caballero-Fonseca F. Mite-induced inflammation: more than allergy. Allergy Rhinol (Providence). 2012; 3:e25-9.
94. Blanco C, Quiralte J, Castillo R et al. Anaphylaxis after ingestion of wheat flour contaminated with mites. J Allergy Clin Immunol 1997; 99:308-13.
95. Zambonino MA, Torres MJ, Muñoz C et al. Drug provocation tests in the diagnosis of hypersensitivity reactions to nonsteroidal anti-inflammatory drugs in children. Pediatr Allergy Immunol 2013; 24:151-9.
96. Takahama H, Kubota Y, Mizoguchi M. A case of anaphylaxis due to ibuprofen. J Dermatol 2000; 27:337-40.
97. Quiralte J, Blanco C, Castillo R, Ortega N, Carrillo T. Anaphylactoid reactions due to nonsteroidal antiinflammatory drugs: clinical and cross-reactivity studies. Ann Allergy Asthma Immunol 1997; 78:293-6.
98. Garcia-Martin E, Ayuso P, Martinez C, Blanca M, Agundez JA. Histamine pharmacogenomics. Pharmacogenomics. 2009; 10:867-83.
99. Agundez JA, Ayuso P, Cornejo-Garcia JA et al. The diamine oxidase gene is associated with hypersensitivity resp-onse to non-steroidal anti-inflammatory drugs. PLoS ONE 2012; 7:e47571.
100. Barranco P, Bobolea I, Larco JI, Prior N, Lopez-Serrano MC, Quirce S. Diagnosis of aspirin-induced asthma combining the bronchial and the oral challenge tests: a pilot study. J Investig Allergol Clin Immunol 2009; 19:446-52.
101. Shi J, Misso NL, Duffy DL et al. Cyclooxygenase-1 gene polymorphisms in patients with different asthma phenotypes and atopy. Eur Respir J 2005; 26:249-56.
102. Corriveau MN, Zhang N, Holtappels G, Van Roy N, Bachert C. Detection of Staphylococcus aureus in nasal tissue with peptide nucleic acid-fluorescence in situ hybridization. Am J Rhinol Allergy. 2009; 23:461-5.
103. Gjomarkaj M, Pace E, Canonica GW et al. GA(2)LEN (Global Allergy and Asthma European Network): European network of excellence for asthma and allergic diseases. Minerva Med 2009; 100:525-34.
104. Asero R. Intolerance to nonsteroidal anti-inflammatory drugs might precede by years the onset of chronic urticaria. J Allergy Clin Immunol 2003; 111:1095-8.
105. Settipane RA, Constantine HP, Settipane GA. Aspirin intolerance and recurrent urticaria in normal adults and children. Epidemiology and review. Allergy 1980; 35:149-54.
106. Stevenson DD, Simon RA. Sensitivity to aspirin and nonsteroidal anti-inflammatory drugs. In: Middleton E, Reed CE, Ellis EF, Adkinson NF Jr, Yunginger JW, Busse WW, eds. Middleton's Allergy: Principles and Practice. 4th Edn. St Louis: Mosby, 1993, 1747-65.
107. Doña I, Rondón C, Campo P et al. Patients with acute urticaria/angioedema to NSAIDs do not evolve to chronic urticaria. J Allergy Clin Immunol AAAAI 2013 Annual Meeting; 2013; 137:AB168.
108. Doña I, Blanca-Lopez N, Jagemann LR et al. Response to a selective COX-2 inhibitor in patients with urticaria/angioedema induced by nonsteroidal anti-inflammatory drugs. Allergy 2011; 66:1428-33.
109. Asero R. Tolerability of rofecoxib. Allergy 2001; 56:916-7.
110. Sánchez Borges M, Capriles-Hulett A, Caballero-Fonseca F, Pérez CR. Tolerability to new COX-2 inhibitors in NSAID-sensitive patients in cutaneous reactions. Ann Allergy Asthma Immunol 2001; 87:201-4.
111. Kowalski ML, Makowska J. Use of nonsteroidal anti-inflammatory drugs in patients with aspirin hypersensitivity: safety of cyclo-oxygenase-2 inhibitors. Treat Respir Med. 2006; 5:399-406.
112. Mastalerz L, Sanak M, Gawlewicz A, Gielicz A, Faber J, Szczeklik A. Different eicosanoid profile of the hypersensitivity reactions triggered by aspirin and celecoxib in a patient with sinusitis, asthma, and urticaria. J Allergy Clin Immunol 2006; 118:957-8.
113. Koschel D, Cardoso C, Leucht V, Hoffken G. Asthmatic reaction induced by Etoricoxib in a patient with aspirin-sensitive asthma. Allergy 2008; 63:1093-4.
114. Viola M, Quaratino D, Volpetti S, Gaeta F, Romano A. Parecoxib tolerability in patients with hypersensitivity to nonsteroidal anti-inflammatory drugs. J Allergy Clin Immunol 2006; 117:1189-91.
115. Sanchez-Borges M, Caballero-Fonseca F, Capriles-Hulett A. Safety of etoricoxib, a new cyclooxygenase 2 inhibitor, in patients with nonsteroidal anti-inflammatory drug-induced urticaria and angioedema. Ann Allergy Asthma Immunol 2005; 95:154-8.
116. Weberschock TB, Muller SM, Boehncke S, Boehncke WH. Tolerance to coxibs in patients with intolerance to non-steroidal anti-inflammatory drugs (NSAIDs): a systematic structured review of the literature. Arch Dermatol Res 2007; 299:169-75.
117. Bochenek G, Nizankowska E, Szczeklik A. The atopy trait in hypersensitivity to nonsteroidal anti-inflammatory drugs. Allergy 1996; 51:16-23.
118. Acevedo N, Vergara C, Mercado D, Jimenez S, Caraballo L. The A-444C polymorphism of leukotriene C4 synthase gene is associated with IgE antibodies to Dermatophagoides pteronyssinus in a Colombian population. J Allergy Clin Immunol 2007; 119:505-7.
119. Lamoureux J, Stankova J, Rola-Pleszczynski M. Leukotriene D4 enhances immunoglobulin production in CD40-activated human B lymphocytes. J Allergy Clin Immunol 2006; 117:924-30.
120. Kim DC, Hsu FI, Barrett NA et al. Cysteinyl leukotrienes regulate Th2 cell-dependent pulmonary inflammation. J Immunol 2006; 176:4440-8.
121. Kim HA, Ye YM, Kim SH, Hur GY, Park HS. Association of beta 2-adrenergic receptor polymorphism with the phenotype of aspirin-intolerant acute urticaria. Yonsei Med J 2007; 48:1079-81.
122. Martin-Iglesias S, del-Cura-Gonzalez I, Sanz-Cuesta T et al. Effectiveness of an implementation strategy for a breastfeeding guideline in Primary Care: cluster randomised trial. BMC Fam Pract 2011; 12:144.
123. Kasemsarn P, Kulthanan K, Tuchinda P, Dhana N, Jongjarearnprasert K. Cutaneous reactions to non-steroidal anti-inflammatory drugs. J Drugs Dermatol 2011; 10:1160-7.
124. Doña I, Campo P, Sanak M et al. Nasal inflammatory mediators in non-steroidal antiinflammatory drugs (NSAIDs) cross-intolerant subjects after lysine nasal challenge. J Investig Allergol Clin Immunol 2012; 129:AB71.
125. Izumi K, Aihara M, Ikezawa Z. Effects of non steroidal antiinflammatory drugs (NSAIDs) on immediate-type food allergy analysis of Japanese cases from 1998 to 2009. Arerugi. 2009; 58:1629-39.
126. Suzuki Y, Ra C. Analysis of the mechanism for the development of allergic skin inflammation and the application for its treatment: aspirin modulation of IgE-dependent mast cell activation: role of aspirin-induced exacerbation of immediate allergy. J Pharmacol Sci. 2009; 110:237-44.
127. Lambert GP, Boylan M, Laventure JP, Bull A, Lanspa S. Effect of aspirin and ibuprofen on GI permeability during exercise. Int J Sports Med 2007; 28:722-6.
128. Matsuo H, Kaneko S, Tsujino Y et al. Effects of non-steroidal anti-inflammatory drugs (NSAIDs) on serum allergen levels after wheat ingestion. J Dermatol Sci 2009; 53:241-3.
129. Pascal M, Munoz-Cano R, Reina Z et al. Lipid transfer protein syndrome: clinical pattern, cofactor effect and profile of molecular sensitization to plant-foods and pollens. Clin Exp Allergy 2012; 42:1529-39.
130. Morita E, Kunie K, Matsuo H. Food-dependent exercise-induced anaphylaxis. J Dermatol Sci 2007; 47:109-17.
131. Cornejo-García JA, Jagemann LR, Blanca-López N et al. Genetic variants of the arachidonic acid pathway in non-steroidal anti-inflammatory drug-induced acute urticaria. Clin Exp Allergy 2012; 42:1772-81.
132. Kim SH, Ye YM, Lee SK, Park HS. Genetic mechanism of aspirin-induced urticaria/angioedema. Curr Opin All-ergy Clin Immunol 2006; 6:266-70.
133. Sanak M, Pierzchalska M, Bazan-Socha S, Szczeklik A. Enhanced expression of the leukotriene C(4) synthase due to overactive transcription of an allelic variant associated with aspirin-intolerant asthma. Am J Respir Cell Mol Biol 2000; 23:290-6.
134. Choi JH, Kim SH, Bae JS et al. Lack of an association between a newly identified promoter polymorphism (-1702G > A) of the leukotriene C4 synthase gene and aspirin-intolerant asthma in a Korean population. Tohoku J Exp Med 2006; 208:49-56.
135. Sayers I, Barton S, Rorke S et al. Promoter polymorphism in the 5-lipoxygenase (ALOX5) and 5-lipoxygenase-activating protein (ALOX5AP) genes and asthma susceptibility in a Caucasian population. Clin Exp Allergy 2003; 33:1103-10.
136. Kowalski ML, Ptasinska A, Jedrzejczak M et al. Aspirin-triggered 15-HETE generation in peripheral blood leukocytes is a specific and sensitive Aspirin-Sensitive Patients Identification Test (ASPITest). Allergy 2005; 60:1139-45.
137. Park JS, Chang HS, Park CS et al. Association analysis of cysteinyl-leukotriene receptor 2 (CYSLTR2) polymorphisms with aspirin intolerance in asthmatics. Pharmacogenet Genomics 2005; 15:483-92.
138. Song YS, Yang EM, Kim SH, Jin HJ, Park HS. Effect of genetic polymorphism of ALOX15 on aspirin-exacerbated respiratory disease. Int Arch Allergy Immunol 2012; 159:157-61.
139. Kim SH, Choi JH, Park HS et al. Association of thromboxane A2 receptor gene polymorphism with the phenotype of acetyl salicylic acid-intolerant asthma. Clin Exp Allergy 2005; 35:585-90.
140. Akahoshi M, Obara K, Hirota T et al. Functional promoter polymorphism in the TBX21 gene associated with aspirin-induced asthma. Hum Genet 2005; 117:16-26.
141. Sánchez-Borges M, Acevedo N, Vergara C et al. The A-444C polymorphism in the leukotriene C4 synthase gene is associated with aspirin-induced urticaria. J Investig Allergol Clin Immunol 2009; 19:375-82.
142. Palikhe NS, Kim SH, Lee HY, Kim JH, Ye YM, Park HS. Association of thromboxane A2 receptor (TBXA2R) gene polymorphism in patients with aspirin-intolerant acute urticaria. Clin Exp Allergy 2011; 41:179-85.
143. Kim SH, Bae JS, Holloway JW et al. A polymorphism of MS4A2 (- 109T > C) encoding the beta-chain of the high-affinity immunoglobulin E receptor (FcepsilonR1beta) is associated with a susceptibility to aspirin-intolerant asthma. Clin Exp Allergy 2006; 36:877-83.
144. Palikhe NS, Kim SH, Kim JH, Losol P, Ye YM, Park HS. Role of toll-like receptor 3 variants in aspirin-exacerbated respiratory disease. Allergy Asthma Immunol Res 2011; 3:123-7.
145. Palikhe NS, Kim SH, Jin HJ, Nam YH, Park HS. Association of interleukin 10 promoter polymorphism at -819 T>C with aspirin-induced urticaria in a Korean population. Ann All-ergy Asthma Immunol 2011; 107:544-6.
146. Choi JH, Kim SH, Cho BY, Lee SK, Suh CH, Park HS. Association of TNF-alpha promoter polymorphisms with aspirin-induced urticaria. J Clin Pharm Ther 2009; 34:231-8.
147. Mastalerz L, Setkowicz M, Sanak M, Rybarczyk H, Szczeklik A. Familial aggregation of aspirin-induced urticaria and leukotriene C synthase allelic variant. Br J Dermatol 2006; 154:256-60.
148. Bae JS, Kim SH, Ye YM et al. Significant association of FcepsilonRIalpha promoter polymorphisms with aspirin-intolerant chronic urticaria. J Allergy Clin Immunol 2007; 119:449-56.
149. Kimura K, Suzuki Y, Sugano S, Koike A. Computation of rank and select functions on hierarchical binary string and its application to genome mapping problems for short-read DNA sequences. J Comput Biol 2009; 16:1601-13.
150. Kim JH, Park BL, Cheong HS et al. Genome-wide and follow-up studies identify CEP68 gene variants associated with risk of aspirin-intolerant asthma. PLoS ONE 2010; 5:e13818.
151. Cheong HS, Park SM, Kim MO et al. Genome-wide methylation profile of nasal polyps: relation to aspirin hypersensitivity in asthmatics. Allergy 2011; 66:637-44.